TRIAL_ID,DRUG_NAME,PHASE,STATUS,TOTAL_PATIENTS,SUCCESSFUL_OUTCOMES,EFFICACY_RATE,NORMALIZED_PATIENTS,CI_LOWER,CI_UPPER,EFFICACY_CATEGORY
101,Test Small Molecule 01,Phase 3,Completed,100,85,0.85,0.67,0.77,0.91,High Efficacy
103,Test Monoclonal Antibody 01,Phase 3,Completed,120,90,0.75,1.00,0.69,0.81,Moderate Efficacy